Potenza Insulated vs Non-Insulated Tips: What the FDA Clearance Does and Doesn't Say
Potenza’s FDA clearance summary is specific about one thing: tip count. Six electrode tip types for the motorized handpiece, three needle tip types for the AC handpiece. All nine ship single-use and sterile.
The same filing lists a maximum output of 50 watts, ten adjustment levels, two operating frequencies at 1MHz and 2MHz, and a needle insertion depth of up to 4.0 millimeters. The indications-for-use field names only electrocoagulation and hemostasis of soft tissue — no mention of skin laxity, pore size, or any cosmetic endpoint. The device is classified under 21 CFR 878.4400, a Class II electrosurgical cutting and coagulation device.
Nine tip types, counted precisely. What the summary never states, for any of them, is whether the needle shaft is insulated or bare. That’s the single distinction patients hear about most often in a consultation room, and it’s absent from the clearance paperwork entirely.
The pad, and the mode that skips it
The summary describes Potenza running in two modes: monopolar and bipolar. In monopolar operation, the tip’s active electrode pairs with a return pad attached elsewhere on the patient’s body, and current travels through tissue between the two to complete the circuit. The pad has low contact resistance, so it generates no meaningful heat; resistance is concentrated at the tip, and that’s where tissue warms and coagulates. The filing doesn’t specify where on the body the pad goes.
Bipolar mode drops the pad. Current passes between adjacent needles within the same tip, so the circuit closes entirely inside the treatment head. Both modes are selected and adjusted from the same touchscreen console — what changes between a monopolar and bipolar pass isn’t the machine, it’s the path the current takes.
The distinction mattered to the reviewers too. Both predicate devices cited in the clearance were bipolar-only; Potenza’s added monopolar capability is logged as the point of difference. AGNES was pulled in as a reference device specifically because it also supports monopolar RF, according to the summary.
What changes between 1MHz and 2MHz
The two frequencies sit side by side in the filing, and the performance testing section lists output accuracy verified separately for monopolar and bipolar operation at each — 1MHz and 2MHz are treated as two distinct, independently validated operating points.
How frequency behaves inside tissue is explained not by the regulatory filing but by published review literature. RF penetration depth runs inversely with frequency — lower frequencies reach deeper — and most microneedle RF platforms on the market operate at either 1MHz or 2MHz. Tissue impedance, the resistance tissue presents to current, rises with frequency between 100kHz and 1MHz and then flattens out above that range.
One number is easy to misread here. The 4.0-millimeter figure in the clearance summary is a needle insertion depth spec — it says nothing about how deep thermal effect reaches at either frequency. Neither the clearance document nor the review literature maps 1MHz or 2MHz to a specific millimeter depth of thermal spread.
Where the insulation question stops in the paperwork
Insulated needles are built with a silicone double-wrap around the shaft, leaving only the terminal 300 micrometers exposed as active electrode; that exposed tip is typically gold-plated to improve conductivity, according to the review. Non-insulated needles run the opposite way — the entire needle length functions as active electrode.
In porcine skin studies, insulated needles produced a teardrop-shaped coagulation zone concentrated at the needle tip, with no coagulation forming between adjacent needles. A separate study using non-insulated needles reported individual coagulation columns forming around each needle, with no reaction occurring between the needle and the epidermis.
But the same review includes a finding that cuts against the tidy version of this story: the research team behind one of these studies concluded there was no meaningful difference in coagulation zone between insulated and non-insulated needles, and no epidermal thermal damage with either. The claim that insulation protects the epidermis isn’t a settled consensus in the literature.
Where Potenza itself falls on this spectrum isn’t answered here either. The review sorts named devices into categories — Infini and Ultracel as insulated-only, Intensif, Secret, Explore, and Scarlet as non-insulated-only, Bodyshape and Vivace as offering both — and Potenza doesn’t appear on that list. The 510(k) summary counts tips. It doesn’t classify them by insulation.
Why practitioners avoid firing the same spot twice
Under Joule’s law, cited in the review, heat generated is a function of current squared, tissue resistance, and conduction time. Of those three variables, resistance shifts by person, by anatomical site, and by how hydrated the skin is — a cited table puts dry and wet skin conductivity at 0.03 and 0.25 S/m, respectively, a wide spread.
As tissue temperature climbs, impedance drops steadily until coagulation begins, then spikes sharply once moisture evaporates around 90 to 100 degrees Celsius. That’s the basis for the review’s caution against stacking — firing repeated passes at the same depth and settings over the same spot. The first pass has already altered the tissue’s resistance, so a second pass at identical settings delivers an inconsistent, unpredictable dose of energy.
The recommended approach instead is to start at the deepest treatment depth and step the depth down with each subsequent pass, building layers rather than repeating one. As depth decreases, both energy level and pulse duration should be reduced in step — a rule the review specifies applies particularly to insulated needles. Repeating passes with non-insulated needles, by contrast, showed no added benefit.
The review also points to which settings actually drive outcomes. Across histology studies, needle depth and pulse duration were the variables that significantly changed the extent of coagulation; energy level was not. That undercuts comparing devices purely by their peak wattage — the number that gets marketed most often isn’t the one the histology says matters most.
What the review confirmed, and what it didn’t
The testing on record is fairly granular: output accuracy for both monopolar and bipolar modes, frequency, output variation characteristics, impedance measurement accuracy and range, needle depth, motor speed steps, and a heating test conducted under electrosurgical device guidance. Electrical safety and electromagnetic compatibility were confirmed against the IEC 60601 standards series.
Animal testing and human clinical trials were both deemed unnecessary — the reviewers concluded the device’s differences from its predicates didn’t require them. That means this clearance file contains no data evaluating cosmetic outcomes like scarring or skin elasticity. What the clearance actually establishes is narrower: that the device coagulates and achieves hemostasis of soft tissue at a level equivalent to existing electrosurgical devices already on the market.
Which leaves a short checklist worth raising in consultation, right after the device name comes up. Is today’s treatment running monopolar, with a return pad attached, or bipolar, current passing only between needles? Is the tip insulated or non-insulated? How many depth levels are planned, and how many passes at each? The first question has an answer sitting in the clearance filing. The other two only exist in the manufacturer’s tip specification sheets and in the settings the practitioner chooses that day.
Entities covered in this article
Sources checked
Scope — This article explains devices and technology. It does not provide individual diagnosis or treatment advice.